Kyo S - Search Results

1

Caspase-8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells.

Komata T, Kondo Y, Kanzawa T, Ito H, Hirohata S, Koga S, Sumiyoshi H, Takakura M, Inoue M, Barna BP, Germano IM, Kyo S, Kondo S. Komata T, et al. Among authors: kyo s. Hum Gene Ther. 2002 Jun 10;13(9):1015-25. doi: 10.1089/104303402753812421. Hum Gene Ther. 2002. PMID: 12067435

2

Down-regulation of telomerase activity in malignant glioma cells by p27KIP1.

Kanzawa T, Komata T, Kyo S, Germano IM, Kondo Y, Kondo S. Kanzawa T, et al. Among authors: kyo s. Int J Oncol. 2003 Dec;23(6):1703-8. Int J Oncol. 2003. PMID: 14612944

3

Combination of caspase transfer using the human telomerase reverse transcriptase promoter and conventional therapies for malignant glioma cells.

Takeuchi H, Kanzawa T, Kondo Y, Komata T, Hirohata S, Kyo S, Kondo S. Takeuchi H, et al. Among authors: kyo s. Int J Oncol. 2004 Jul;25(1):57-63. Int J Oncol. 2004. PMID: 15201989

4

Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status.

Ito H, Kanzawa T, Miyoshi T, Hirohata S, Kyo S, Iwamaru A, Aoki H, Kondo Y, Kondo S. Ito H, et al. Among authors: kyo s. Hum Gene Ther. 2005 Jun;16(6):685-98. doi: 10.1089/hum.2005.16.685. Hum Gene Ther. 2005. PMID: 15960600 Free PMC article.

5

A novel telomerase-specific gene therapy: gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter.

Koga S, Hirohata S, Kondo Y, Komata T, Takakura M, Inoue M, Kyo S, Kondo S. Koga S, et al. Among authors: kyo s. Hum Gene Ther. 2000 Jul 1;11(10):1397-406. doi: 10.1089/10430340050057477. Hum Gene Ther. 2000. PMID: 10910137

6

Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter.

Komata T, Kondo Y, Kanzawa T, Hirohata S, Koga S, Sumiyoshi H, Srinivasula SM, Barna BP, Germano IM, Takakura M, Inoue M, Alnemri ES, Shay JW, Kyo S, Kondo S. Komata T, et al. Among authors: kyo s. Cancer Res. 2001 Aug 1;61(15):5796-802. Cancer Res. 2001. PMID: 11479218

7

FADD gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter to restrict induction of apoptosis to tumors in vitro and in vivo.

Koga S, Hirohata S, Kondo Y, Komata T, Takakura M, Inoue M, Kyo S, Kondo S. Koga S, et al. Among authors: kyo s. Anticancer Res. 2001 May-Jun;21(3B):1937-43. Anticancer Res. 2001. PMID: 11497281

8

A novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptase gene promoter.

Komata T, Koga S, Hirohata S, Takakura M, Germano IM, Inoue M, Kyo S, Kondo S, Kondo Y. Komata T, et al. Among authors: kyo s. Int J Oncol. 2001 Nov;19(5):1015-20. doi: 10.3892/ijo.19.5.1015. Int J Oncol. 2001. PMID: 11605003

9

Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide.

Kanzawa T, Germano IM, Kondo Y, Ito H, Kyo S, Kondo S. Kanzawa T, et al. Among authors: kyo s. Br J Cancer. 2003 Sep 1;89(5):922-9. doi: 10.1038/sj.bjc.6601193. Br J Cancer. 2003. PMID: 12942127 Free PMC article.

10

Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy?

Kyo S, Inoue M. Kyo S, et al. Oncogene. 2002 Jan 21;21(4):688-97. doi: 10.1038/sj.onc.1205163. Oncogene. 2002. PMID: 11850797 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

704 results

Search Page

Filters